Late Onset VOD: Evidence; Practice and UK Funding (A focus on Severe LO VOD)
25 May 2021
About the event
During this 90 minutes webinar Professor Antonio Pagliuca and Dr Varun Mehra; from Kings College Hospital; will talk about the importance of recognising and treating late onset VOD; supported by recently published real world evidence and a clinical case of severe LO VOD management; as well as the new funding of Defitelio for the severe LO VOD in England.
Jazz Pharmaceuticals is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients. We are focused on developing life-changing medicines for people with serious diseases — often with limited or no options — so they can live their lives more fully. By transforming biopharmaceutical discoveries into novel medicines, we are working to give people around the world the opportunity to redefine what’s possible – to make the “small wins” big again.
